N2Growth Blog

OCTOBER 23, 2023

Additionally, the industry’s highly regulated nature means that executives must have a keen eye for compliance and a strong ability to navigate the ever-changing market dynamics. Top executive search firms also bring a unique set of resources and expertise to the table when it comes to attracting top talent for biotech companies.

Biotech 178

Biotech Strategy Artificial Inteligence Recruiting 178

TechCrunch

DECEMBER 16, 2022

“While it may feel counterintuitive, given the recent market environment, the value of the equity for all parties — investors, founders and employees — is higher in the more conservative growth scenario,” says Mitchem. 6 investors discuss why AI is more than just a buzzword in biotech. Target audience/market size slide.

Case Study 215

Case Study Biotech Survey Study 215

Crunchbase News

JANUARY 6, 2025

Although 2024 was another exceptionally lackluster year for new public offerings, the IPO market could gain momentum in 2025 after its three-year lull. With that in mind, here are 13 companies that the Crunchbase News team thinks could be top contenders to go public if our 2025 market forecast bears out. That made sense.

Marketing 129

Marketing Company Technical Review Fintech 129

Crunchbase News

JANUARY 7, 2025

Table of Contents Breakout year for AI Q4 push Large values, billion-dollar rounds US gained, Silicon Valley fired up Late-stage Q4 boom Early stage flat Seed settled Liquidity hold-up Methodology Glossary of funding terms Related reading Breakout year for AI One thing was clear: 2024 was the breakout year for funding to AI companies.

Artificial Inteligence 144

Artificial Inteligence Artificial Intelligence Report Technical Review 144

TechCrunch

NOVEMBER 22, 2022

million in a funding round led by Sequoia India and Southeast Asia’s Surge as it plans to expand the market for its medical imagery annotations solution. Artificial intelligence has become ubiquitous in clinical diagnosis. “We see ourselves building the foundational layer of artificial intelligence in healthcare.

Artificial Inteligence 234

Artificial Inteligence Artificial Intelligence Biotech 3D 234

TechCrunch

MAY 31, 2022

The appetite for genomic data continues to rise in the field of biotech and pharmaceutical research, but cost is still a factor — even sequencing a full genome now costs as little as $1,000. The third advance involves machine learning to accelerate the process of turning optical data (the CD-style scanning signal) into usable data.

Biotech 315

Biotech Pharmaceuticals Study Artificial Inteligence 315

TechCrunch

DECEMBER 2, 2020

Sifting through the trillions of molecules out there that might have powerful medicinal effects is a daunting task, but the solution biotech has found is to work smarter, not harder. Machine learning has, of course, accelerated work in many fields, biochemistry among them, but he felt that the potential of the technology had not been tapped.

Biotech 265

Biotech 3D Artificial Inteligence Machine Learning 265

Crunchbase News

NOVEMBER 22, 2024

Just as the holiday season begins, a sleighful of companies unveiled large funding rounds. xAI , $5B, artificial intelligence: Generative AI startup xAI raised $5 billion in a funding round valuing it at $50 billion, The Wall Street Journal reported. The $6 billion round valued the company at $24 billion post money.

Artificial Inteligence 122

Artificial Inteligence Artificial Intelligence Biotech Generative AI 122

TechCrunch

NOVEMBER 16, 2022

AI and proteins have been in the news lately, but largely because of the efforts of research outfits like DeepMind and Baker Lab. Their machine learning models take in easily collected RNA sequence data and predict the structure a protein will take — a step that used to take weeks and expensive special equipment.

Generative AI 206

Generative AI Artificial Inteligence Biotech Machine Learning 206

TechCrunch

MARCH 17, 2023

Best practices for leveraging artificial intelligence and machine learning in 2023 Zero-based budgeting: A proven framework for extending runway Image Credits: Getty Images It’s critical to make every dollar count in this environment, but pulling back too much in the wrong places can reduce momentum across your entire organization. “The

Budget 230

Budget Biotech Artificial Inteligence Banking 230

TechCrunch

JUNE 6, 2022

Insilico Medicine, a Hong Kong-based company that has been using artificial intelligence to discover new drugs since 2014, has completed a fresh round of funding. “Right now the market is in ‘biotechnology winter’ where many companies are running out of cash and are dying.

Biotech 211

Biotech Artificial Inteligence Artificial Intelligence Pharmaceuticals 211

TechCrunch

MAY 26, 2021

So a new crop of biotech companies have worked to integrate these aspects. The money will go toward the requisite testing and paperwork involved in bringing a new drug to market based on promising leads. 2021 should be a banner year for biotech startups that make smart choices early.

Engineering 248

Engineering Biotech Chemicals Artificial Inteligence 248

TechCrunch

APRIL 6, 2022

Navigating the choppy e-commerce seas : As reporter Ingrid Lunden writes, “e-commerce is synonymous with shopping on Amazon, but the reality is that a retailer has the option to use a bundle of different channels to sell and market products.” 6 questions investors should ask when evaluating psychedelic biotech companies. Big Tech Inc.

Marketing 235

Marketing Biotech Retail 3D 235

TechCrunch

JANUARY 10, 2023

German-based biotech company BioNTech — one of the big manufacturers of COVID-19 vaccines, among other things — is set to acquire InstaDeep , a Tunis-born and U.K.-based It gives brands a way to conduct market research and collect first-party data, which is important as marketers prepare for a post-cookie world. Startups and VC.

Trends 219

Trends Marketing ChatGPT Windows 219

Crunchbase News

DECEMBER 15, 2023

The week was especially good for biotech, which led the way with two big raises. Tome Biosciences , $213M, biotech: A big biotech raise hit high on the list this week. Bicara Therapeutics , $165M, biotech: If Bicara Therapeutics looks familiar, it’s because this isn’t its first time on this list.

Biotech 122

Biotech Artificial Inteligence Artificial Intelligence Hotels 122

TechCrunch

JUNE 1, 2021

Its machine learning systems predict the best ways to synthesize potentially valuable molecules, a crucial part of creating new drugs and treatments. The company leverages machine learning and a large body of knowledge about chemical reactions to create these processes, though as CSO Stanis?aw odarczyk-Pruszy?

Chemicals 246

Chemicals Artificial Inteligence Off-The-Shelf Machine Learning 246

Crunchbase News

JUNE 28, 2024

Formation Bio , $372M, biotech: Every week there is a big biotech raise and this week’s is really big. More and more biotech startups are using AI to help with their drug processes and investors are clearly taking note. Sidecar Health believes a free-market approach will ensure healthcare is more accessible and affordable.

Artificial Inteligence 116

Artificial Inteligence Biotech Generative AI Healthcare 116

TechCrunch

JANUARY 25, 2022

Meanwhile, the company is developing machine learning algorithms with the ability to pick out subpar cells. . In an increasingly hot biotech market, protecting IP is key. She’ll plan to expand the machine learning capacity of the platform — a key part of making Cellino’s platform truly autonomous.

Artificial Inteligence 246

Artificial Inteligence Machine Learning Biotech Study 246

TechCrunch

JANUARY 25, 2022

The Tunisian startup, headquartered in London with offices in Paris, Tunis, Lagos, Dubai and Cape Town, uses advanced machine learning techniques to bring AI to applications within an enterprise environment. Other examples are the design of advanced therapeutics with silicon and routing components on a printed circuit board.

Enterprise 246

Enterprise Artificial Inteligence Machine Learning Transportation 246

Crunchbase News

SEPTEMBER 13, 2024

Biotech and AI had another strong week, as the sectors saw two big nine-figure rounds each — including one for $370 million in biotech. Candid Therapeutics , $370M, biotech: Every week there’s a big biotech raise — and this week there’s one that’s really big. Check out last week’s biggest funding rounds here.

Biotech 77

Biotech Artificial Inteligence Artificial Intelligence Healthcare 77

Crunchbase News

AUGUST 9, 2024

billion — the highest amount invested at this stage in two years — that increase was concentrated in larger fundings and in two leading sectors — healthcare/biotech and AI. As the market tightened, seed-stage companies faced a more challenging environment in which to raise a Series A round. While total funding reached $31.5

Biotech 136

Biotech Artificial Inteligence Artificial Intelligence Healthcare 136

CIO

MAY 15, 2024

The biotech company Moderna , for example, is aiming to use ChatGPT Enterprise to “automate nearly every business process” in order to “outpace its plan to roll out 15 new products within the next five years.” And with every passing day, “your guess is as good as mine” will become an increasingly uncomfortable answer.

Artificial Inteligence 195

Artificial Inteligence Generative AI Biotech Artificial Intelligence 195

Crunchbase News

OCTOBER 1, 2024

However, it wasn’t just AI that got funding in September, as biotech makes up about half the list. Safe Superintelligence , $1B, artificial intelligence: AI research lab Safe Superintelligence raised $1 billion from a litany of big-name investors including Andreessen Horowitz and Sequoia Capital.

Biotech 120

Biotech Artificial Inteligence Artificial Intelligence Travel 120

Crunchbase News

JUNE 27, 2024

For the past few years the M&A market for startups has been slow — and the IPO pipeline nonexistent. However, just as AI is taking over venture, perhaps it is doing that for the M&A and IPO markets. Last week, artificial intelligence chips startup Cerebras Systems reportedly filed confidentially for an initial public offering.

Marketing 127

Marketing Artificial Inteligence Artificial Intelligence Biotech 127

N2Growth Blog

JANUARY 10, 2024

The life sciences industry is characterized by unique challenges and complexities, requiring leaders who deeply understand scientific advancements, regulatory frameworks, and highly dynamic market conditions.

Biotech 97

Biotech Leadership Recruiting Trends 97

Crunchbase News

AUGUST 2, 2024

Outpace Bio , $144M, biotech: The big biotech raise of the week came from Outpace Bio. The biotech uses AI-powered protein design to program immune cells battling tumors. The company also uses artificial intelligence to help members get care faster. The new round was led by Aliment Capital.

Biotech 124

Biotech Artificial Inteligence Artificial Intelligence Insurance 124

Crunchbase News

FEBRUARY 28, 2025

After a couple of blistering weeks, large funding rounds slowed down to a crawl, with only two rounds hitting nine figures. Not surprisingly, those two rounds came from the cybersecurity and biotech industries. Eikon Therapeutics , $351M, biotech: Eikon Therapeutics raised one of the biggest biotech rounds thus far in this young year.

Biotech 75

Biotech Artificial Inteligence Artificial Intelligence Healthcare 75

Crunchbase News

JUNE 7, 2024

Pika , $80M, artificial intelligence: It never takes us long to get to an AI startup on this list. Pika, an artificial intelligence startup that generates video, raised an $80 million round led by Spark Capital that values the Palo Alto, California-based company at $470 million, per Bloomberg.

Energy 126

Energy Biotech 3D Artificial Inteligence 126

Crunchbase News

JUNE 14, 2024

AI, biotech, space tech and cybersecurity also saw good-sized raises. Clearly GM is betting — big — the autonomous driving and robotaxi market comes back. The New York-based startup’s market intelligence and search platform — powered by AI and natural language processing — helps clients form corporate and investment strategies.

Biotech 129

Biotech Technical Review Artificial Inteligence Artificial Intelligence 129

Crunchbase News

JULY 2, 2024

Clearly GM is betting — big — the autonomous driving and robotaxi market comes back. AlphaSense , $650M, artificial intelligence: AI-driven market intelligence platform AlphaSense raised $650 million in funding co-led by Viking Global Investors and BDT & MSD Partners at a $4 billion valuation — a 75% increase from just nine months ago.

Artificial Inteligence 127

Artificial Inteligence Biotech Software Review Healthcare 127

TechCrunch

SEPTEMBER 28, 2021

In an increasingly hot biotech market, protecting IP is key. Lifebit says it has a patented technology for federating the data around genomic data, allowing researchers to get more insights while keeping the data secure. Privacy issues are regularly raised around genomic data.

Biotech 248

Biotech Data Government Research 248

TechCrunch

APRIL 23, 2021

A biotech company that has spent 11 years researching supplements to increase human longevity plans to launch its supplements later this year. How and when to build marketing teams at deep tech companies. Longevica says it created a biotechnology platform for longevity after researching the life-span of laboratory mice.

Research 261

Research Biotech Nonprofit Comparison 261

CIO

APRIL 17, 2024

A chief commercial officer of a clothing company learned to use Midjourney to create images of new clothing products. Normally, a CCO develops ideas about what the market needs and communicates them to a design team, which produces sketches to then be reviewed by the CCO. The second is the tools go beyond coding assistance.

Software Review 194

Software Review Enterprise Generative AI Artificial Inteligence 194

Crunchbase News

JULY 12, 2024

After a quiet holiday week, investors were back in action dishing out big rounds to startups in robotics, biotech, healthcare and more. Element Biosciences , $277M, biotech: It’s hard to get through a week without a big biotech raise, and this one’s no different. based companies? Check out The Crunchbase Megadeals Board.

Biotech 121

Biotech Artificial Inteligence Artificial Intelligence Healthcare 121

Crunchbase News

FEBRUARY 16, 2024

Not exactly sure what was in the water this week, but AI and biotech led the way as happens often. Lambda , $320M, artificial intelligence: In a big week, this was the biggest round. The company offers cloud computing services and hardware for training artificial intelligence software. billion valuation.

Lambda 125

Lambda Biotech Artificial Inteligence Artificial Intelligence 125

Crunchbase News

OCTOBER 18, 2024

Terray Therapeutics , $120M, biotech: Los Angeles-based Terray Therapeutics, a biotech startup developing small molecule drug therapeutics, raised a $120 million Series B led by new investor Bedford Ridge Capital and existing investor NVentures. Founded in 2021, the company has raised nearly $318 million, per Crunchbase.

Energy 114

Energy Artificial Inteligence Artificial Intelligence Biotech 114

TechCrunch

OCTOBER 5, 2021

Andiamo uses machine learning, 3D simulation and 3D printing to create custome braces for children with cerebral palsy, bringing down the cost and improving outcomes for clinicians, patients and families alike. Frontrunner combines sports betting with the flexibility of the stock market. departments.

Company 208

Company Meeting Sport 3D 208